Lactic acidosis: From sour milk to septic shock

Journal of Intensive Care Medicine

Volumn 20, Issue 5, 2005, Pages 255-271

  Fall, Pamela J ^a   Szerlip, Harold M ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Bicarbonate; Hemofiltration; Hypoperfusion; Hypoxia; Lactate; Lactic acidosis; Pyruvate; Shock; SIRS

Indexed keywords

ACETIC ACID DERIVATIVE; ADRENALIN; ANTIRETROVIRUS AGENT; BICARBONATE; BIGUANIDE DERIVATIVE; CARBICARB; CARNITINE; DICHLOROACETIC ACID; ISONIAZID; LACTIC ACID; LACTULOSE; LINEZOLID; METFORMIN; NALIDIXIC ACID; NEOMYCIN; NICOTINIC ACID; NITROPRUSSIDE SODIUM; PARACETAMOL; PHENFORMIN; PROPOFOL; SALICYLIC ACID; SIMVASTATIN; STAVUDINE; THEOPHYLLINE; TRIBONAT; TROMETAMOL; UNCLASSIFIED DRUG; UNINDEXED DRUG; VANCOMYCIN; VASOACTIVE AGENT; ZIDOVUDINE;

ALCOHOL INTOXICATION; ALKALOSIS; ASTHMATIC STATE; CLINICAL TRIAL; CYANIDE POISONING; DIABETES MELLITUS; DISEASE COURSE; DRUG MECHANISM; DRUG WITHDRAWAL; FATTY LIVER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERKALEMIA; HYPERNATREMIA; HYPEROSMOLALITY; HYPOALBUMINEMIA; HYPOGLYCEMIA; INTENSIVE CARE UNIT; LACTATE BLOOD LEVEL; LACTIC ACIDOSIS; LIVER TOXICITY; MALIGNANT NEOPLASTIC DISEASE; MYOPATHY; NEUROPATHY; NONHUMAN; ORGAN PERFUSION; PRIORITY JOURNAL; PROGNOSIS; RENAL REPLACEMENT THERAPY; RESPIRATION DEPRESSION; REVIEW; SEPTIC SHOCK; SIDE EFFECT; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

ACIDOSIS, LACTIC; BICARBONATES; BIOLOGICAL MARKERS; BUFFERS; DRUG TOXICITY; HUMANS; LACTIC ACID; RENAL REPLACEMENT THERAPY; SEVERITY OF ILLNESS INDEX; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 30544441255     PISSN: 08850666     EISSN: 15251489     Source Type: Journal    
DOI: 10.1177/0885066605278644     Document Type: Review

References (177)

1. Luft D, Deichsel G, Schmulling RM, et al. Definition of clinically relevant lactic acidosis in patients with internal diseases. Am J Clin Pathol. 1983;80:484-489.
2. Huckabee WE. Abnormal resting blood lactate. I. The significance of hyperlactatemia in hospitalized patients. Am J Med. 1961;30:833-839.
3. Huckabee WE. Abnormal resting blood lactate. II. Lactic acidosis. Am J Med. 1961;30:840-848.
4. Cohen RD, Woods HF. Clinical and Biochemical Aspects of Lactic Acidosis. Osney Meade, Oxford, UK: Blackwell Scientific; 1976.
5. Madias NE. Lactic acidosis. Kidney Int. 1986;29:752-774.
6. Kreisberg RA. Lactic acidosis: an update. J Intensive Care Med. 1987;2:76-84.
7. Stacpoole PW. Lactic acidosis. Endocrinol Metab Clin North Am. 1993;22:221-245.
8. Bellomo R. Bench-to-bedside review: lactate and the kidney. Crit Care2E 2002;6:322-326.
9. Yudkin J, Cohen RD. The contribution of the kidney to the removal of a lactic acid load under normal and acidotic conditions in the conscious rat. Clin Sci Mol Med. 1975;48:121-131.
10. Gauthier PM, Szerlip HM. Metabolic acidosis in the intensive care unit. Crit Care Clin. 2002;18:1-20.
11. Rowell LB, Kraning KK II, Evans TO, et al. Splanchnic removal of lactate and pyruvate during prolonged exercise in man. J Appl Physiol. 1966;21:1773-1783.
12. Mizock BA. Controversies in lactic acidosis: implications in critically acidosis. JAMA. 1987;258:497-501.
13. Zilva JF. The origin of acidosis in hyperlactatemia. Ann Clin Biochem. 1978;15:40-43.
14. Robergs RA. Exercise-induced metabolic acidosis: where do the protons come from? Sportscience 5. Available at: spoitsci.org/jour/0102/rar.htm,2001.
15. Robergs RA. Biochemistry of exercise-induced metabolic acidosis. J Appl Pbysiol Regul Integr Comp Physiol. 2004;287:R502-R516.
16. Orringer CE, Eustace JC, Wunsch CD, et al. Natural history of lactic acidosis after grand-mal seizures. N Engl J Med. 1977;297:796-799.
17. Osnes JB, Hermansen L. Acid-base balance after maximal exercise of short duration. J Appl Physiol. 1972;32:59-63.
18. Kreisberg RA. Lactate homeostasis and lactic acidosis. Ann Intern Med. 1980;92:227-237.
19. Schroder R, Gumpert JRW, Pluth JR, et al. The role of the liver in the development of lactic acidosis in low flow states. Postgrad Med J. 1969;45:566-570.
20. Arieff AI, Park R, Leach WJ, et al. Pathophysiology of experimental lactic acidosis in dogs. Am J Physiol. 1980;239:F135-F142.
21. Lloyd MH, Iles RA, Simpson BR, et al. The effect of simulated metabolic acidosis on intracellular pH and lactate metabolism in the isolated perfused rat liver. Clin Sci Mol Med. 1973;45:543-549.
22. Trivedi B, Danforth WH. Effect of pH on the kinetics of frog muscle phosphofructokinase. J Biol Chem. 1966;241:4110-4114.
23. Nelimarkka O, Halkola L, Niinikoski J. Renal hypoxia and lactate metabolism in hemorrhagic shock in dogs. Crit Care Med. 1984;12:656-660.
24. Emmett M, Narins RG. Clinical use of the anion gap. Medicine. 1977;56:38-54.
25. Gabow PA. Disorders associated with altered anion gap. Kidney Int. 1985;27:472-483.
26. Iberti TJ, Leibowitz AB, Papadakos PJ, et al. Low sensitivity of the anion gap as a screen to detect hyperlactatemia in critically ill patients. Crit Care Med. 1990;18:275-277.
27. Saleem MM, Mujais SK. Gaps in the anion gap. Arch Intern Med. 1992;152:1625-629.
28. Ishihara K, Szerlip HM. Anion gap acidosis. Semin Nephrol. 1998;18:83-97.
29. Figge J, Jabor A, Kazda A, et al. Anion gap and hypoalbuminemia. Crit Care Med. 1998;26:1807-1810.
30. Bersin RM, Arieff AI. Primary lactic alkalosis. Am J Med. 1988;85:867-871.
31. Constable PD. Clinical assessment of acid-base status: comparison of the Henderson-Hasselbalch and strong ion approaches. Vet Clin Pathol. 2000;29:115-128.
32. Fend V, Leith DE. Stewart's quantitative acid-base chemistry: applications in biology and medicine. Respir Physiol. 1993;91:1-16.
33. Stewart PA. How to Understand Acid-Base: A Quantitative Acid-Base Primer for Biology and Medicine. New York, NY: Elsevier North Holland; 1981.
34. Fend V, Jabor A, Kazda A, et al. Diagnosis of metabolic acid-base disturbances in critically ill patients. Am J Respir Crit Care Med. 2000;162:2246-2251.
35. Stacpoole PW, Wright EC, Baumgartner TG, et al. Natural history and course of acquired lactic acidosis in adults. Am J Med. 1994;97:47-54.
36. Silverman HJ. Lack of a relationship between induced changes in oxygen consumption and changes in lactate levels. Chest. 1991;100:1012-1015.
37. Hurtado FJ, Gutierrez AM, Silva N, et al. Role of tissue hypoxia as the mechanism of lactic acidosis during E. coli endotoxemia. J Appl Physiol. 1992;72:1895-1901.
38. Gore DC, Jahoor F, Hibbert JM, et al. Lactic acidosis during sepsis is related to increased pyruvate production, not deficits in tissue oxygen availability. Ann Surg. 1996;224:97-102.
39. Vary TC, Siegel JH, Nakatani T, et al. Effect of sepsis on activity of pyruvate dehydrogenase complex in skeletal muscle and liver. Am J Physiol. 1986;250:E634-E640.
40. Vary TC. Increased pyruvate dehydrogenase kinase activity in response to sepsis. Am J Physiol. 1991;260:E669-E674.
41. Vary TC, Siegel JH, Rivkind A. Clinical and therapeutic significance of metabolic patterns of lactic acidosis. Perspectives Crit Care. 1988;1:85-132.
42. 2 endotoxemic dogs during shock and resuscitation. J Appl Physiol. 1994;76:793-800.
43. Tenhunen JJ, Uusaro A, Karja V, et al. Apparent heterogeneity of regional blood flow and metabolic changes within splanchnic tissues during experimental endotoxin shock. Anesth Analg. 2003;97:555-563.
44. Brown SD, Clark C, Gutierrez G. Pulmonary lactate release in patients with sepsis and the adult respiratory distress syndrome. J Crit Care. 1996;11:2-8.
45. Kellum JA, Kramer DJ, Lee K, et al. Release of lactate by the lung in acute lung injury. Chest. 1997;111:1301-1305.
46. Falk JL, Rackow EC, Leavy J, et al. Delayed lactate clearance in patients surviving circulatory shock. Acute Care. 1985;11:212-215.
47. Severin PN, Uhing MR, Beno DWA, et al. Endotoxin-induced hyperlactatemia results from decreased lactate clearance in hemodynamically stable rats. Crit Care Med. 2002;30:2509-2514.
48. Chrusch C, Bands C, Bose D, et al. Impaired hepatic extraction and increased splanchnic production contribute to lactic acidosis in canine sepsis. Am J Respir Crit Care Med. 2000;161:517-526.
49. Berger M, Haag SA, Goodman MN, et al. Glucose metabolism in perfused skeletal muscle: effects of starvation, diabetes, fatty acids, acetoacetate, insulin and exercise on glucose uptake and disposition. Biochem J. 1976;158:191-202.
50. Reaven GM, Hollenbeck C, Jeng CY, et al. Measurement of plasma glucose, free fatty acid, lactate, and insulin for 24 h in patients with NIDDM. Diabetes. 1988;37:1020-1024.
51. Block JB. Lactic acidosis in malignancy and observations on its possible pathogenesis. Ann NY Acad Sci. 1974;230:94-102.
52. Scheurleer-Hommes MLL, Schaafsma MR, Kluin-Nelemans JC. Lactic acidosis in a patient with B-cell non-Hodgkin's lymphoma. Leukemia. 1994;8:1065-1066.
53. Ali AA, Flombaum CD, Brochstein JA, et al. Lactic acidosis and renal enlargement at diagnosis and relapse of acute lymphoblastic leukemia. J Pediatr. 1994;124:584-586.
54. Mizock BA, Glass JN. Lactic acidosis in a patient with multiple myeloma. West J Med. 1994;161:417-418.
55. Ustun C, Fall P, Szerlip HM, et al. Multiple myeloma associated with lactic acidosis. Leukemia and Lymphoma. 2002;43:2395-2397.
56. Weber G. Enzymology of cancer cells (second of two parts). N Engl J Med. 1977;296:541-551.
57. Sculier JP, Nicaise C, Klastersky J. Lactic acidosis: a metabolic complication of extensive metastatic cancer. Eur J Cancer Clin Oncol. 1983;19:597-601.
58. Pearlman BL, Fenves AZ, Emmett M. Metformin-associated lactic acidosis. Am J Med. 1996;101:109-110.
59. Owen MR, Doran E, Halestrap AP. Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain. Biochem J. 2000;348:607-614.
60. Chang CT, Chen YC, Fang JT, et al. Metformin-associated lactic acidosis: case reports and literature review. J Nephrol. 2002;15:398-402.
61. Gan SC, Barr J, Arieff AI, et al. Biguanide-associated lactic acidosis. Case report and review of the literature. Arch Intern Med. 1992;152:2333-2336.
62. Jones GC, Macklin JP, Alexander WD. Contraindications to the use of metformin: evidence suggests that it is time to amend the list. BMJ. 2003;326:4-5.
63. Brown JB, Pedula K, Barzilay J, et al. Lactic acidosis rates in type 2 diabetes. Diabetes Care. 1998;21:1659-1663.
64. Levey AS, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med. 1999;130:461-470.
65. Chattha G, Arieff AI, Cummings C, et al. Lactic acidosis complicating the acquired immunodeficiency syndrome. Ann Intern Med. 1993;118:37-39.
66. Carr A, Cooper DA. Adverse effects of antiretroviral therapy. Lancet. 2000;356:1423-1430.
67. Claessens YE, Chiche JD, Mira JP, et al. Bench-to-bedside review: severe lactic acidosis in HIV patients treated with nucleoside analogue reverse transcriptase inhibitors. Crit Care. 2003;7:226-232.
68. Cote HCF, Brumme ZL, Craib KJP, et al. Changes in mitochondrial DNA as a marker of nucleoside toxicity in HIV-infected patients. N Engl J Med. 2002;346:811-820.
69. John M, Moore CB, James IR, et al. Chronic hyperlactatemia in HIV-infected patients taking antiretroviral therapy. AIDS. 2001;15:717-723.
70. Marceau G, Sapin V, Jacomet C, et al. Frequency, risk factors, and outcome of hyperlactatemia in HIV-positive persons: implications for the management of treated patients. Clin Chem. 2003;49:1154-1162.
71. Delgado J, Harris M, Tesiorowski A, et al. Symptomatic elevations of lactic acid and their response to treatment manipulation in human immunodeficiency virus-infected persons: a case series. CID. 2001;33:2072-2074.
72. Hocqueloux L, Alberti C, Feugeas JP, et al. Prevalence, risk factors and outcome of hyperlactataemia in HIV-infected patients. HIV Med. 2003;4:18-23.
73. Claessens YE, Cariou A, Monchi M. et al. Detecting life-threatening lactic acidosis related to nucleoside-analog treatment of human immunodeficiency virus-infected patients, and treatment with L-carnitine. Crit Care Med. 2003;31:1042-1047.
74. Miller KD, Cameron M, Wood LV et al. Lactic acidosis and hepatic steatosis associated with use of stavudine: report of four cases. Ann Intern Med. 2000;133:192-196.
75. Lonergan JT, Behling C, Pfander H, et al. Hyperlactatemia and hepatic abnormalities in 10 human immunodeficiency virus-infected patients receiving nucleoside analogue combination regimens. Clin Infect Dis. 2000;31:162-166.
76. Brinkman K. Management of hyperlactatemia: no need for routine lactate measurements. AIDS. 2001;15:795-797.
77. Fulop M, Bock J, Ben-Ezra J, et al. Plasma lactate and 3-hydroxybutyrate levels in patients with acute ethanol intoxication. Am J Med. 1986;80:191-194.
78. MacDonald L, Kruse JA, Levy DB, et al. Lactic acidosis and acute ethanol intoxication. Am J Emerg Med. 1994;12:32-35.
79. Wilson KC, Reardon C, Farber HW. Propylene glycol toxicity in a patient receiving intravenous diazepam. N Engl J Med. 2000;343:815.
80. Kashyap AS, Kashyap S. Case of the month. Am J Med. 2000;109:591.
81. Reynolds HN, Teiken P, Regan ME, et al. Hyperlactatemia, increased osmolar gap, and renal dysfunction during continuous lorazepam infusion. Crit Care Med. 2000;28:1631-1634.
82. Tayar J, Jabbour G, Saggi SJ. Severe hyperosmolar metabolic acidosis due to a large dose of intravenous lorazepam. N Engl J Med. 2002;346:1253-1254.
83. Vasile B, Rasulo F, Candiani A, et al. The pathophysiology of propofol infusion syndrome: a simple name for a complex syndrome. Intensive Care Med. 2003;29:1417-1425.
84. Madias NE, Goorno WE, Herson S. Severe lactic acidosis as a presenting feature of pheochromocytoma. Am J Kidney Dis. 1987;10:250-253.
85. Murphy FT, Manoen TJ, Knutson SW, et al. Epinephrine-induced lactic acidosis in the setting of status asthmaticus. South Med J. 1995;88:577-579.
86. Day NPJ, Phu NH, Bethell DP, et al. The effects of dopamine and adrenaline infusions on acid-base balance and systemic haemodynamics in severe infection. Lancet. 1996;348:219-223.
87. Eichenholz A, Mulhausen RO, Redleaf PS. Nature of acid-base disturbance in salicylate intoxication. Metabolism. 1963;12:164-175.
88. Alvarez FG, Guntupalli KK. Isoniazid overdose: four case reports and review of the literature. Intensive Care Med. 1995;21:641-644.
89. Earthman TP, Odom L, Mullins CA. Lactic acidosis associated with high-dose niacin therapy. South Med. J. 1991;84:496-497.
90. Dash H, Mills J. Severe metabolic acidosis associated with nalidixic acid overdose. Ann Intern Med. 1976;84:570-571.
91. Goli AK, Goli SA, Byrd RP, et al. Simvastatin-induced lactic acidosis: a rare adverse reaction? Clin Pharmacol Ther. 2002;72:461-464.
92. Humphrey SH, Nash DA. Lactic acidosis complicating sodium nitroprusside therapy. Ann Intern Med. 1978;88:58-59.
93. Apodaca AA, Rakita RM. Linezolid-induced lactic acidosis. N Engl J Med. 2003;348:86-87.
94. Mann NS, Russman HB, Mann SK, et al. Lactulose and severe lactic acidosis. Ann Intern Med. 1985;103:637.
95. Kushner RF. Total parenteral nutrition-associated metabolic acidosis. J Parenter Enteral Nutr. 1986;10:306-310.
96. Rickett, JWS, Bowen DJ. Danger of intravenous fructose. Lancet. 1973;1:489-490.
97. Bastone GF, Alberti KGMM, Dewar AK. Reversible lactic acidosis associated with repeated intravenous infusions of sorbitol and ethanol. Postgrad Med J. 1977;53:567-569.
98. Wells FE, Smits BJ. Utilization and metabolic effects of a solution of amino acids, sorbitol, and ethanol in parenteral nutrition. Am J Clin Nutr. 1978;31:442-450.
99. Silverman B, Franklin GM, Bolin R, et al. Lactic acidosis traced to thiamine deficiency related to nationwide shortage of multivitamins for total parenteral nutrition-United States. MMWR Morb Mortal Wkly Rep. 1997;46:523-528.
100. Chadda K, Raynard B, Antoun S, et al. Acute lactic acidosis with Wernicke's encephalopathy due to thiamine deficiency. Intensive Care Med. 2002;28:1499.
101. Mock DM, DeLorimer AA, Liebman WM, et al. Biotin deficiency: an unusual complication of parenteral alimentation. N Engl J Med. 1981;304:820-823.
102. Stacpoole PW. Lactic acidosis and other mitochondrial disorders. Metabolism. 1997;46:306-321.
103. Neiberger RE, George JC, Perkins LA, et al. Renal manifestations of congenital lactic acidosis. Am J Kidney Dis. 2003;39:12-23.
104. Clay AS, Behnia M, Brown KK. Mitochondrial disease: a pulmonary and critical-care medicine perspective. Chest. 2001;120:634-648.
105. Oh MS, Phelps KR, Traube M, et al. D-lactic acidosis in a man with the short-bowel syndrome. N Engl J Med. 1979;301:249-252.
106. Stolberg L, Rolfe R, Gitlin N, et al. D-lactic acidosis due to abnormal gut flora: diagnosis and treatment of two cases. N Engl J Med. 1982;306:1344-1348.
107. Halverson J, Gale A, Lazarus C, et al. D-lactic acidosis and other complications of intestinal bypass surgery. Arch Intern Med. 1984;144:357-360.
108. Mason PD. Metabolic acidosis due to D-lactate. BMJ. 1986;292:1105-1106.
109. Spital A, Sterns RH. Metabolic acidosis following jejunoileal bypass. Am J Kidney Dis. 1994;23:135-137.
110. Bongaerts G, Tolboom J, Bakkeren J, et al. D-lactic academia and aciduria in pediatric and adult patients with short bowel syndrome. Clin Chem2E 1995;41:107-110.
111. Vella A, Farrugia G. D-lactic acidosis: pathologic consequence of saprophytism. Mayo Clin Proc. 1998;73:451-456.
112. Halperin ML, Kamel KS. D-lactic acidosis: turning sugar into acids in the gastrointestinal tract. Kidney Int. 1996;49:1-8.
113. Zhang DL, Jiang ZW, Jiang J, et al. D-lactic acidosis secondary to short bowel syndrome. Postgrad Med J. 2003;79:110-112.
114. Uribarri J, Oh MS, Carroll HJ. D-lactic acidosis: a review of clinical presentation, biochemical features, and pathophysiologic mechanisms. Medicine. 1998;77:73-82.
115. Dahlquist NR, Perrault J, Callaway CW, et al. D-lactic acidosis and encephalopathy after jejunoileostomy: response to overfeeding and to fasting in humans. Mayo Clin Proc. 1984;59:141-145.
116. Ramakrishnan T, Stokes P. Beneficial effects of fasting and low carbohydrate diet in D-lactic acidosis associated with short bowel syndrome. JPEN J Parenter Enteral Nutr. 1985;9:361-363.
117. Cheifetz LM, Schulman SR, Greeley WJ, et al. Serum lactates correlate with mortality after operations for complex congenital heart disease. Ann Thorac Surg. 1997;64:735-738.
118. Hatherill M, McIntyre AG, Wattie M, et al. Early hyperlactataemia in critically ill children. Intensive Care Med. 2000;26:314-318.
119. Fuloria M. Elevated plasma lactate levels: a tool for predicting outcomes or for improving care. Crit Care Med. 2002;30:2166-2167.
120. Cady LD, Weil MW, Afifi AA, et al. Quantitation of severity of critical illness with special reference to blood lactate. Crit Care Med. 1973;1:75-80.
121. Bernardin G, Pradier C, Tiger F, et al. Blood pressure and arterial lactate level are early indicators of short-term survival in human septic shock. Intensive Care Med. 1996;22:17-25.
122. Anderson CT, Westgard JO, Schlimgen K, et al. Contribution of arterial blood lactate measurement to the care of critically ill patients. Am J Clin Pathol. 1977;68:63-67.
123. Cerovic O, Golubovie V, Spec-Marn A, et al. Relationship between injury severity and lactate levels in severely injured patients. Intensive Care Med. 2003;29:1300-1305.
124. Meregalli A, Oliveira RP, Friedman G. Occult hypoperfusion is associated with increased mortality in hemodynamically stable, high-risk, surgical patients. Crit Care. 2004;8:R60-R65.
125. Kaplan LJ, Kellum JA. Initial pH, base deficit, lactate, anion gap, strong ion difference, and strong ion gap predict outcome from major vascular surgery. Crit Care Med. 2004;32:1120-1124.
126. Husain FA, Martin MJ, Mullenix PS, et al. Serum lactate and base deficit as predictors of mortality and morbidity. Am J Surg. 2003;185:485-491.
127. Nguyen HB, Rivers EP, Knoblich BP, et al. Early lactate clearance is associated with improved outcome in severe sepsis and septic shock. Crit Care Med. 2004;32:1637-1642.
128. McNelis J, Marini CP, Jurkiewicz A, et al. Prolonged lactate clearance is associated with increased mortality in the surgical intensive care unit. Am J Surg. 2001;182:481-485.
129. Newman TS, Magnuson TH, Ahrendt SA, et al. The changing face of mesenteric ischemia. Am Surg. 1998;64:611-616.
130. Baud FJ, Borron SW, Megarbane B, et al. Value of lactic acidosis in the assessment of the severity of acute cyanide poisoning. Crit Care Med. 2002;30:2044-2050.
131. Mochizuki S, Kobayashi K, Neely JR. Effects of L-lactate on glyceraldehyde-3-P dehydrogenase in heart muscle. Recent Adv Stud Cardiac Struct Metab. 1976;12:175-182.
132. Yatani A, Fujino T, Kinoshita K, et al. Excess lactate modulates ionic currents and tension components in frog atrial muscle. J Mol Cell Cardiol. 1981;13:147-161.
133. Wildenthal K, Mierzwiak DS, Myers RW, et al. Effects of acute lactic acidosis on left ventricular performance. Am J Physiol. 1968;214:1352-1359.
134. Orchard CH, Kentish JC. Effects of changes of pH on the contractile function of cardiac muscle. Am J Physiol. 1990;258:C967-C981.
135. Bonventre JV, Cheung JY. Effects of metabolic acidosis on viability of cells exposed to anoxia. Am J Physiol. 1985;249:C149-C159.
136. Thorens JB, Jollier P, Ritz M, et al. Effects of rapid permissive hypercapnia on hemodynamics, gas exchange, and oxygen transport and consumption during mechanical ventilation for the acute respiratory distress syndrome. Intensive Care Med. 1996;22:182-191.
137. Carvalho CRR, Barbas CSV, Medeiros DM, et al. Temporal hemodynamic effects of permissive hypercapnia associated with ideal PEEP in ARDS. Am J Respir Crit Care Med. 1997;156:1458-1466.
138. Morris LR, Murphy MB, Kitabchi AE. Bicarbonate therapy in severe diabetic ketoacidosis. Ann Intern Med. 1986;105:836-840.
139. Maury E, Vassal T, Offenstadt G. Cardiac contractility during severe ketoacidosis. N Engl J Med. 1999;341:1938.
140. Guyton AC. Textbook of Medical Physiology. Philadelphia, PA: Saunders; 1981:509-510.
141. Forsythe SM, Schmidt GA. Sodium bicarbonate for the treatment of lactic acidosis. Chest. 2000;117:260-267.
142. Kraut JA, Kurtz I. Use of base in the treatment of severe acidemic states. Am J Kidney Dis. 2001;38:703-727.
143. Levraut J, Grimaud D. Treatment of metabolic acidosis. Curr Opin Crit Care. 2003;9:260-265.
144. Bersin RM. Effects of sodium bicarbonate on myocardial metabolism and circulatory function during hypoxia. In: Areiff A, ed. Hypoxia, Metabolic Acidosis, and the Circulation. Oxford, UK: Oxford University Press; 1992:139-174.
145. Arieff AI, Leach W, Park R, et al. Systemic effects of NaHCO3 in experimental lactic acidosis in dogs. Am J Physiol. 1982;242:F586-F591.
146. Graf H, Leach W, Arieff AI. Metabolic effects of sodium bicarbonate in hypoxic lactic acidosis. Am J Physiol. 1985;249:F630-F635.
147. Cooper DJ, Herbertson MJ, Werner HA, et al. Bicarbonate does not increase left ventricular contractility during L-lactic academia in pigs. Am Rev Respir Dis. 1993;148:317-322.
148. Cooper DJ, Walley KR, Wiggs BR, et al. Bicarbonate does not improve hemodynamics in critically ill patients who have lactic acidosis. Ann Intern Med. 1990;112:492-498.
149. Mathieu D, Neviere R, Billard V, et al. Effects of bicarbonate therapy on hemodynamics and tissue oxygenation in patients with lactic acidosis: a prospective, controlled clinical study. Crit Care Med. 1991;19:1352-1356.
150. Bersin RM, Chatterjee K, Arieff AI. Metabolic and hemodynamic consequences of sodium bicarbonate administration in patients with heart disease. Am J Med. 1989;87:7-14.
151. Cuhaci B, Lee J, Ahmed Z. Sodium bicarbonate and intracellular acidosis: myth or reality? Crit Care Med. 2001;29:1088-1090.
152. Levraut J, Giunti C, Ciebiera JP, et al. Initial effect of sodium bicarbonate on intracellular pH depends on the extracellular nonbicarbonate buffering capacity. Crit Care Med. 2001;29:1033-1039.
153. Bersin RM, Arieff AI. Improved hemodynamic function during hypoxia with carbicarb, a new agent for the management of acidosis. Circulation. 1988;77:227-233.
154. Shapiro JI, Elkins N, Logan J, et al. Effects of bicarbonate, disodium carbonate, and a sodium bicarbonate/carbonate mixture on the PCO2 of blood in a closed system. J Lab Clin Med. 1995;126:65-69.
155. Rhee KH, Toro LO, McDonald GG, et al. Carbicarb, sodium bicarbonate, and sodium chloride in hypoxic lactic acidosis. Effect on arterial blood gases, lactate concentrations, hemodynamic variables, and myocardial intracellular pH. Chest. 1993;104:913-918.
156. Leung JM, Landow L, Franks M, et al. Safety and efficacy of intravenous Carbicarb in patients undergoing surgery: comparison with sodium bicarbonate in the treatment of metabolic acidosis. Crit Care Med. 1994;22:1540-1549.
157. Nahas GG, Sutin KM, Fermon C, et al. Guidelines for the treatment of acidaemia with THAM. Drugs. 1998;55:191-224.
158. Weber T, Tschernich H, Sitzwohl, et al. Tromethamine buffer modifies the depressant effect of permissive hypercapnia on myocardial contractility in patients with acute respiratory distress syndrome. Am J Respir Crit Care Med. 2000;162:1361-1365.
159. Kallet RH, Jasmer RM, Luce JM, et al. The treatment of acidosis in acute lung injury with tris-hydroxymethyl aminomethane (THAM). Am J Respir Crit Care Med. 2000;161:1149-1153.
160. Bjerneroth G. Tribonat®-a comprehensive summary of its properties. Crit Care Med. 1999;27:1009-1013.
161. Stacpoole PW. The pharmacology of dichloroacetate. Metabolism. 1989;38:1124-1144.
162. Stacpoole PW, Nagaraja NV, Hutson AD. Efficacy of dichloroacetate as a lactate-lowering drug. J Clin Pharmacol. 2003;43:683-691.
163. Stacpoole PW, Wright EC, Baumgartner TG, et al. A controlled clinical trial of dichloroacetate for treatment of lactic acidosis in adults. N Engl J Med. 1992;327:1564-1569.
164. Hilton PJ, Taylor J, Forni LG, et al. Bicarbonate-based haemofiltration in the management of acute renal failure with lactic acidosis. Q J Med. 1998;91:279-283.
165. Honore PM, Jamez J, Wauthier M, et al. Prospective evaluation of short-term, high-volume isovolemic hemofiltration on the hemodynamic course and outcome in patients with intractable circulatory failure from septic shock. Crit Care Med. 2000;28:3581-3587.
166. Vaziri ND, Ness R, Wellikson L, et al. Bicarbonate-buffered peritoneal dialysis: an effective adjunct in the treatment of lactic acidosis. Am J Med. 1979;67:392-396.
167. Levraut J, Ciebiera JP, Jambou P, et al. Effect of continuous venovenous hemofiltration with dialysis on lactate clearance in critically ill patients. Crit Care Med. 1997;25:58-62.
168. Lang RM, Fellner SK, Neumann A, et al. Left ventricular contractility varies directly with blood ionized calcium. Ann Intern Med. 1988;108:524-529.
169. Barenbrock M, Hausberg M, Matzkies F, et al. Effects of bicarbonate- and lactate-buffered replacement fluids on cardiovascular outcome in CVVH patients. Kidney Int. 2000;58:1751-1757.
170. Thomas AN, Guy JM, Kishen R, et al. Comparison of lactate and bicarbonate buffered haemofiltration fluids: use in critically ill patients. Nephrol Dial Transplant. 1997;12:1212-1217.
171. Schetz M. Non-renal indications for continuous renal replacement therapy. Kidney Int. 1999;56:S-88-S-94.
172. DeVriese AS, Colardyn FA, Philippe JJ, et al. Continuous removal during continuous hemofiltration in septic patients. J Am Soc Nephrol. 1999;10:846-853.
173. Oudemans-van Straaten HM, Bosman RJ, van der Spoel JI, et al. Outcome of critically ill patients treated with intermittent high-volume haemofiltration: a prospective cohort analysis. Intensive Care Med. 1999;25:814-821.
174. Ronco C, Bellomo R, Homel P, et al. Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomized trial. Lancet. 2000;356:26-30.
175. Sheppard JM, Lawrence JR, Oon RCS, et al. Lactic acidosis: recovery with use of peritoneal dialysis. Aust N Z J Med. 1972;4:389-392.
176. Schmidt R, Horn E, Richards J, et al. Survival after metformin-associated lactic acidosis in peritoneal dialysis-dependent renal failure. Am J Med. 1997;102:486-488.
177. Barrueto F, Meggs WJ, Barchman MJ. Clearance of metformin by hemofiltration in overdose. Clin Toxicol. 2002;40:177-180.